BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16861036)

  • 1. Anthrax toxins: A paradigm of bacterial immune suppression.
    Baldari CT; Tonello F; Paccani SR; Montecucco C
    Trends Immunol; 2006 Sep; 27(9):434-40. PubMed ID: 16861036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthrax toxins: a weapon to systematically dismantle the host immune defenses.
    Tournier JN; Rossi Paccani S; Quesnel-Hellmann A; Baldari CT
    Mol Aspects Med; 2009 Dec; 30(6):456-66. PubMed ID: 19560486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses.
    Xu L; Frucht DM
    Int J Biochem Cell Biol; 2007; 39(1):20-4. PubMed ID: 17008119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin.
    Agrawal A; Lingappa J; Leppla SH; Agrawal S; Jabbar A; Quinn C; Pulendran B
    Nature; 2003 Jul; 424(6946):329-34. PubMed ID: 12867985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity.
    Fukao T
    Lancet Infect Dis; 2004 Mar; 4(3):166-70. PubMed ID: 14998502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the interaction of Bacillus anthracis with cells of the innate immune response.
    Mayer-Scholl A
    Berl Munch Tierarztl Wochenschr; 2006; 119(5-6):216-21. PubMed ID: 16729468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anthrax revisited: Bacillus anthracis toxins as novel actors of immune escape?].
    Tournier JN; Quesnel-Hellmann A; Cleret A; Mathieu J; Goossens PL; Mock M; Vidal DR
    Bull Acad Natl Med; 2006 Jan; 190(1):155-63; discussion 163-7. PubMed ID: 16878452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resident CD11c+ lung cells are impaired by anthrax toxins after spore infection.
    Cleret A; Quesnel-Hellmann A; Mathieu J; Vidal D; Tournier JN
    J Infect Dis; 2006 Jul; 194(1):86-94. PubMed ID: 16741886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthrax lethal toxin: a weapon of multisystem destruction.
    Agrawal A; Pulendran B
    Cell Mol Life Sci; 2004 Nov; 61(22):2859-65. PubMed ID: 15558214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthrax delivers a lethal blow to host immunity.
    Starnbach MN; Collier RJ
    Nat Med; 2003 Aug; 9(8):996-7. PubMed ID: 12894159
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y; Qiu J; Zhou Y; Farhangfar F; Hester J; Lin AY; Decker WK
    Vaccine; 2008 Jan; 26(5):614-22. PubMed ID: 18166249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signalling.
    Rossi Paccani S; Tonello F; Patrussi L; Capitani N; Simonato M; Montecucco C; Baldari CT
    Cell Microbiol; 2007 Apr; 9(4):924-9. PubMed ID: 17087730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus anthracis lethal toxin negatively modulates ILC3 function through perturbation of IL-23-mediated MAPK signaling.
    Seshadri S; Allan DSJ; Carlyle JR; Zenewicz LA
    PLoS Pathog; 2017 Oct; 13(10):e1006690. PubMed ID: 29059238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes.
    Ingram RJ; Metan G; Maillere B; Doganay M; Ozkul Y; Kim LU; Baillie L; Dyson H; Williamson ED; Chu KK; Ascough S; Moore S; Huwar TB; Robinson JH; Sriskandan S; Altmann DM
    J Immunol; 2010 Apr; 184(7):3814-21. PubMed ID: 20208010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of host signalling pathways by anthrax toxins.
    Turk BE
    Biochem J; 2007 Mar; 402(3):405-17. PubMed ID: 17313374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate Immune Interactions between
    Liu JZ; Ali SR; Bier E; Nizet V
    Front Cell Infect Microbiol; 2018; 8():2. PubMed ID: 29404280
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity.
    Crawford MA; Aylott CV; Bourdeau RW; Bokoch GM
    J Immunol; 2006 Jun; 176(12):7557-65. PubMed ID: 16751402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
    Gupta M; Alam S; Bhatnagar R
    Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling.
    Paccani SR; Tonello F; Ghittoni R; Natale M; Muraro L; D'Elios MM; Tang WJ; Montecucco C; Baldari CT
    J Exp Med; 2005 Feb; 201(3):325-31. PubMed ID: 15699068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.